With hemp rules tightening, users worry about access to THC-infused products
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. HempTHCPolicySleepAging Why This Matters As hemp-derived THC products face tighter regulatory scrutiny, clinicians need…
CBD and CBG: Promising Treatments for Fatty Liver Disease
A new CBD and CBG fatty liver disease study highlights promising therapeutic potential for metabolic liver conditions. These cannabinoids may reduce liver fat and improve metabolic health. This study offers hope for new treatment options beyond lifestyle…
Should Medicare Reimburse Cannabis Products Without FDA Approval? | Newswire
Medicare cannabis reimbursement policy remains uncertain due to the lack of FDA approval for many cannabis products. This affects clinicians' ability to guide patients on coverage and treatment options. Understanding this policy gap is crucial for…
Cannabis May Support Brain Health in Older Adults | The Jerusalem Post
Recent studies suggest cannabis neuroprotective benefits older adults might gain, challenging traditional views on cognitive aging. This research highlights potential brain health support from cannabis in elderly populations. Clinicians should consider…
The Cannabis Mental Health Evidence Gap: Association vs. Causation
The cannabis mental health evidence gap highlights the challenges in distinguishing association from causation in cognitive decline studies. Current research shows no clear link between cannabis use and dementia risk in older adults. Clinicians must…
Research on Cannabis Compounds and Metabolic Dysfunction in Adults
This article explores cannabis compounds metabolic dysfunction and their potential impact on reversing disease affecting one-third of adults. The research highlights emerging findings on cannabis compounds as a possible intervention for metabolic health.…
Cannabis compounds could reverse disease affecting one-third of adults – New York Post
Recent studies highlight non-psychoactive cannabis compounds metabolic disease potential, especially for conditions like metabolic syndrome. These compounds offer therapeutic promise without psychoactive effects. However, clinical validation is needed…
New Study Shows Cannabinoids Reduce Liver Fat Accumulation
Emerging evidence suggests cannabinoids reduce hepatic steatosis, potentially benefiting fatty liver disease. CBD and CBG show promise in preclinical models. Clinical trials are needed to confirm these findings.
Colorado Scientists Discover Cannabis Benefits for Memory and Brain Size in Older People
Emerging research on cannabis brain volume older adults suggests potential benefits for memory and cognitive function. A large study found larger brain volumes in cannabis users aged 40 and older. These findings highlight the need for further research on…
The Florida Cannabis Debate Will Still Be Around
The florida cannabis regulation impact is significant for older adults self-treating with cannabis for pain and sleep. Despite ongoing policy debates, this trend continues to grow. Clinicians need evidence-based guidance to counsel this population…